Roving Reporter Asks: How Should We Redefine Value, Access, and Affordability in Cell and Gene Therapy? - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Roving Reporter Asks: How Should We Redefine Value, Access, and Affordability in Cell and Gene Therapy?

IBTV speaks with industry leaders at ASGCT 2026 about new approaches to manufacturing, reimbursement, treatment delivery, and long-term value that could bring cell and gene therapies to more patients

  • September 11, 2026

  • 2 min

Share

Original Source(s)

Roving Reporter Asks: How Should We Redefine Value, Access, and Affordability in Cell and Gene Therapy?

  • September 11, 2026

Related Content

Correction: Case Report: Complete response and prolonged survival to alectinib in a NSCLC patient with metastases harboring a rare WDR43::ALK structural deletion

Adenotonsillectomy linked to more RTI visits

The findings suggest adenotonsillectomy should not be performed solely to prevent respiratory tract infections in pediatric patients.

Pima Medical Institute Launches Dental Hygiene Program in Phoenix

New 18-month curriculum includes classroom, laboratory and clinical education for students pursuing associate degrees.

  • September 11, 2026

  • 3 min